Effect of Low-Carbohydrate Diet on Beta-Hydroxybutyrate Ketogenesis Metabolic Stimulation and Regulation of NLRP3 Ubiquitination in Obese Saudi Women
Nutrients · 05.02.2023 · 15 (4) · 820
DOI: 10.3390/nu15040820 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nutrients, online erschienen am 05.02.2023. Verfasst von Manal Abdulaziz Binobead und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Food Science and Nutrition, College of Food and Agricultural Sciences, King Saud University, Riyadh 11451, Saudi Arabia. Hauptthemen laut MEDLINE: NLR Family, Pyrin Domain-Containing 3 Protein, Diet, Ketogenic. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Researchers Supporting Project, King Saud University, Riyadh, Saudi Arabia, King Saud University.
Abstract (Originalsprache)
The effects of a ketogenic diet (KD) on anthropometric indices, the lipid profile, and the benefits of the ketone body beta-hydroxybutyrate (BHB) as an inhibitor of the NOD-like receptor pyrin domain-containing 3 (NLRP3) inflammasome in obese women were investigated in this study. From January to March 2021, 23 obese adult women (n = 23) with an average age of 35.30 years and BMI of 33.96 kg/m2 followed a KD. Instructions for the KD were given to eligible participants, with a typical plan and a menu for all the main meals, snacks, and drinks permitted over seven days. They were also free to change meals according to their preferences provided that they followed the plan. The participants attended six times throughout the intervention for measurements of their anthropometric indices, BHB levels, interleukin-1beta (1L-1β) levels, and completion of a questionnaire (pre-intervention, mid-intervention, and post-intervention). Following the KD caused significant weight loss, a reduction in waist circumference and BHB levels, as well as a reduction in BMI and appetite. Cholesterol, triglycerides (TG), and high-density lipoprotein cholesterol (HDL-C) increased slightly. However, low-density lipoprotein cholesterol (LDL-C) in serum increased significantly (p < 0.05), and 1L-1β decreased significantly (p < 0.0001). The results show that the KD effectively encouraged weight loss and NLRP3 inflammasome inhibition. Based on the questionnaire results, it was found that a variety of physical symptoms, including overall energy, physical activity, mood, sleep, focus, skin conditions, and menstruation, had significantly improved.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Food Science and Nutrition, College of Food and Agricultural Sciences, King Saud University, Riyadh 11451, Saudi Arabia.
ORCID-Profile: Sahar Abdulaziz Alsedairy, Laila Naif Al-Harbi, Ghedeir M Alshammari
Förderung
- Researchers Supporting Project, King Saud University, Riyadh, Saudi Arabia
- King Saud University
Zitieren
APA
Binobead, M. A., Aldakhilallah, A. H., Alsedairy, S. A., Al-Harbi, L. N., Al-Qahtani, W. H., & Alshammari, G. M. (2023). Effect of Low-Carbohydrate Diet on Beta-Hydroxybutyrate Ketogenesis Metabolic Stimulation and Regulation of NLRP3 Ubiquitination in Obese Saudi Women. Nutrients, 15(4), 820. https://doi.org/10.3390/nu15040820
Vancouver
Binobead MA, Aldakhilallah AH, Alsedairy SA, Al-Harbi LN, Al-Qahtani WH, Alshammari GM. Effect of Low-Carbohydrate Diet on Beta-Hydroxybutyrate Ketogenesis Metabolic Stimulation and Regulation of NLRP3 Ubiquitination in Obese Saudi Women. Nutrients. 2023;15(4):820. doi:10.3390/nu15040820
BibTeX
@article{Binobead2023,
author = {Binobead, Manal Abdulaziz and Aldakhilallah, Azhar Hamad and Alsedairy, Sahar Abdulaziz and Al-Harbi, Laila Naif and Al-Qahtani, Wahidah H and Alshammari, Ghedeir M},
title = {Effect of Low-Carbohydrate Diet on Beta-Hydroxybutyrate Ketogenesis Metabolic Stimulation and Regulation of NLRP3 Ubiquitination in Obese Saudi Women},
journal = {Nutrients},
year = {2023},
volume = {15},
number = {4},
pages = {820},
doi = {10.3390/nu15040820}
}
EUVIMED